All of the following antidiabetic drugs act by enhancing insulin resistance except
**Question:** All of the following antidiabetic drugs act by enhancing insulin resistance except
A. Metformin
B. Dipeptidyl peptidase-4 (DPP-4) inhibitors
C. Thiazolidinediones
D. Sulfonylureas
**Correct Answer:** .
**Core Concept:**
Antidiabetic drugs are medications used to manage blood glucose levels in patients with diabetes mellitus. They can be broadly classified into insulin secretagogues, insulin sensitizers, and insulin secretagogues that also stimulate insulin secretion. Insulin sensitizers aim to increase the responsiveness of target cells to insulin, thus decreasing glucose levels.
**Why the Correct Answer is Right:**
Metformin is a biguanide that works by decreasing hepatic glucose production and improving insulin sensitivity in skeletal muscles. It does not enhance insulin resistance.
Dipeptidyl peptidase-4 (DPP-4) inhibitors, such as vildagliptin and sitagliptin, act by inhibiting DPP-4 enzyme. This leads to increased levels of incretins (glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)), which in turn enhance insulin secretion, inhibit glucagon secretion, and improve beta-cell function. They do not increase insulin resistance.
Thiazolidinediones, like pioglitazone, act by binding to peroxisome proliferator-activated receptor gamma (PPAR-γ) receptors, which leads to increased insulin sensitivity in muscle, liver, and adipose tissue. This improves glucose uptake and utilization, hence reducing blood glucose levels.
Sulfonylureas, such as gliclazide and glipizide, directly stimulate insulin secretion from pancreatic beta cells through binding to sulfonylurea receptors. They do not enhance insulin resistance.
**Why Each Wrong Option is Incorrect:**
**Option A (Metformin):** Metformin does not increase insulin resistance.
**Option B (DPP-4 inhibitors):** DPP-4 inhibitors improve insulin sensitivity and function, but do not increase insulin resistance.
**Option C (Thiazolidinediones):** Thiazolidinediones increase insulin sensitivity, which is the opposite of enhancing insulin resistance.
**Option D (Sulfonylureas):** Sulfonylureas stimulate insulin secretion, but do not increase insulin resistance.
**Core Concept:**
In summary, these antidiabetic drugs work by different mechanisms: enhancing insulin secretion, improving insulin sensitivity, and improving insulin function, but none of them directly increase insulin resistance.
**Why the Correct Answer is Right:** None of the drugs mentioned increase insulin resistance, as they either stimulate insulin secretion or improve insulin sensitivity or function.
**Clinical Pearls:**
1. The main goal of antidiabetic treatments is to bring blood glucose levels into the normal range, either by increasing insulin sensitivity or secretion, rather than directly increasing insulin resistance. Understanding these mechanisms is crucial for choosing the right treatment option for individual patients based on their specific needs and comorbidities.